The production of interleukin-6 (IL-6) by bone and marrow stromal cells is inhibited by l7beta-estradiol; and estrogen loss (ovariectomy) causes an IL-6-mediated upregulation of osteoclastogenesis in mice. In addition, human IL-11, a newly discovered cytokine which seems to be produced exclusively by bone marrow stromal cells, exhibits osteoclastogenic and bone resorptive properties. Based on this evidence, the following hypothesis will be tested: Loss of estrogen in women, similar to the case with mice, unleashes the production and/or action of cytokines, such as IL-6, in the marrow microenvironment which are, in turn, responsible for an upregulation of hematopoietic progenitors of osteoclasts and increased osteoclast development. To do this, bone marrow aspirates will be obtained during and three months following ovariectomy from 30 premenopausal women and 20 women undergoing hysterectomy without ovariectomy. In addition, 50 ml of venous blood and 30 ml of urine will be obtained prior to the operation and at one, two, and three months after the operation. Using low density cells from the bone marrow aspirate, ex vivo cultures will be established and the formation of colony forming units for granulocyte-erythrocyte- megakaryocyte-monocyte (CFU-GEHM) and the colony forming units for granulocyte-monocyte (CFU-GM), as well as the production of interleukin-6 and interleukin-11 in supernatants and the formation of TRAPase-positive cells that bind 125I-calcitonin in the presence of either 1,25(OH)2D3, PTH, IL-1, IL-11, or the combination of l,25(OH)2D3 and IL-11 will be determined. In addition, the concentration of estradiol, calcium, phosphorus, osteocalcin, l,25(OH)2D3, PTH, and a complete blood count, as well as the concentration of creatinine, hydroxyproline, and pyridinium crosslinks will be measured in the blood and urine samples. Each of the cellular parameters determined in the bone marrow cultures will be examined for possible correlations with the estrogen status, and the markers of bone remodeling. In addition to the clinical protocol and as a secondary goal of the proposal, aliquots of the bone marrow cells from ovariectomized women will be cultured on smooth cortical bone slices and utilized for the systematic exploration of experimental conditions for the formation of bone excavating (pit forming) human osteoclasts in vitro. It is expected that these studies will advance knowledge regarding the mechanism of the osteopenia associated with estrogen loss from the experimental animal models to the human situation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR043003-05
Application #
2667815
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Project Start
1994-03-01
Project End
2000-02-29
Budget Start
1998-03-01
Budget End
2000-02-29
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Qiu, S; Rao, D S; Palnitkar, S et al. (2002) Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. Bone 31:313-8
Qiu, S; Rao, D S; Palnitkar, S et al. (2002) Relationships between osteocyte density and bone formation rate in human cancellous bone. Bone 31:709-11
Kousteni, S; Bellido, T; Plotkin, L I et al. (2001) Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-30
Abe, E; Yamamoto, M; Taguchi, Y et al. (2000) Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15:663-73
Manolagas, S C (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-37
Rao, D S; Honasoge, M; Divine, G W et al. (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85:1054-8
Plotkin, L I; Weinstein, R S; Parfitt, A M et al. (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363-74
Jilka, R L; Weinstein, R S; Bellido, T et al. (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-46
Weinstein, R S; Jilka, R L; Parfitt, A M et al. (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-82
Manolagas, S C (1998) The role of IL-6 type cytokines and their receptors in bone. Ann N Y Acad Sci 840:194-204

Showing the most recent 10 out of 22 publications